156 related articles for article (PubMed ID: 34583319)
1. Mycoplasma Pneumoniae Testing and Treatment Among Children With Community-Acquired Pneumonia.
Desai S; Hall M; Lipsett SC; Shah SS; Brogan TV; Hersh AL; Williams DJ; Grijalva CG; Gerber JS; Blaschke AJ; Neuman MI; Ambroggio L
Hosp Pediatr; 2021 Jul; 11(7):760-763. PubMed ID: 34583319
[TBL] [Abstract][Full Text] [Related]
2. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015].
Aguilera-Alonso D; López Ruiz R; Centeno Rubiano J; Morell García M; Valero García I; Ocete Mochón MD; Montesinos Sanchis E
An Pediatr (Engl Ed); 2019 Jul; 91(1):21-29. PubMed ID: 30679135
[TBL] [Abstract][Full Text] [Related]
5. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
[TBL] [Abstract][Full Text] [Related]
6. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
Chen YC; Hsu WY; Chang TH
Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
[TBL] [Abstract][Full Text] [Related]
7. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
8. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
[TBL] [Abstract][Full Text] [Related]
9. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of macrolide resistance in pediatric
Jiang TT; Sun L; Wang TY; Qi H; Tang H; Wang YC; Han Q; Shi XQ; Bi J; Jiao WW; Shen AD
Front Cell Infect Microbiol; 2023; 13():1181402. PubMed ID: 37249975
[TBL] [Abstract][Full Text] [Related]
11. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia.
Shah SS; Test M; Sheffler-Collins S; Weiss AK; Hall M
J Hosp Med; 2012 Apr; 7(4):311-7. PubMed ID: 22271440
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan.
Wu PS; Chang LY; Lin HC; Chi H; Hsieh YC; Huang YC; Liu CC; Huang YC; Huang LM
Pediatr Pulmonol; 2013 Sep; 48(9):904-11. PubMed ID: 23169584
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia.
Kutty PK; Jain S; Taylor TH; Bramley AM; Diaz MH; Ampofo K; Arnold SR; Williams DJ; Edwards KM; McCullers JA; Pavia AT; Winchell JM; Schrag SJ; Hicks LA
Clin Infect Dis; 2019 Jan; 68(1):5-12. PubMed ID: 29788037
[TBL] [Abstract][Full Text] [Related]
14. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
15. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia.
Fischer JE; Steiner F; Zucol F; Berger C; Martignon L; Bossart W; Altwegg M; Nadal D
Arch Pediatr Adolesc Med; 2002 Oct; 156(10):1005-8. PubMed ID: 12361446
[TBL] [Abstract][Full Text] [Related]
16. Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia.
Zhao MC; Wang L; Qiu FZ; Zhao L; Guo WW; Yang S; Feng ZS; Li GX
BMC Infect Dis; 2019 Oct; 19(1):835. PubMed ID: 31601192
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
Choi JH; Seong GM; Ko Y; Kim YR; Kim C
Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
[No Abstract] [Full Text] [Related]
18. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive
Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK
J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461
[TBL] [Abstract][Full Text] [Related]
19. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV
Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315
[No Abstract] [Full Text] [Related]
20. Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia.
Tang M; Wang D; Tong X; Wu Y; Zhang J; Zhang L; Yin Y; Cao Q
BMC Pediatr; 2021 Feb; 21(1):90. PubMed ID: 33607971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
